Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data

dc.contributor.authorXu, Yuan
dc.contributor.authorKong, Shiying
dc.contributor.authorCheung, Winson Y
dc.contributor.authorBouchard-Fortier, Antoine
dc.contributor.authorDort, Joseph C
dc.contributor.authorQuan, Hude
dc.contributor.authorBuie, Elizabeth M
dc.contributor.authorMcKinnon, Geoff
dc.contributor.authorQuan, May L
dc.date.accessioned2019-03-10T01:03:19Z
dc.date.available2019-03-10T01:03:19Z
dc.date.issued2019-03-08
dc.date.updated2019-03-10T01:03:18Z
dc.description.abstractAbstract Background Recurrence is not explicitly documented in cancer registry data that are widely used for research. Patterns of events after initial treatment such as oncology visits, re-operation, and receipt of subsequent chemotherapy or radiation may indicate recurrence. This study aimed to develop and validate algorithms for identifying breast cancer recurrence using routinely collected administrative data. Methods The study cohort included all young (≤ 40 years) breast cancer patients (2007–2010), and all patients receiving neoadjuvant chemotherapy (2012–2014) in Alberta, Canada. Health events (including mastectomy, chemotherapy, radiation, biopsy and specialist visits) were obtained from provincial administrative data. The algorithms were developed using classification and regression tree (CART) models and validated against primary chart review. Results Among 598 patients, 121 (20.2%) had recurrence after a median follow-up of 4 years. The high sensitivity algorithm achieved 94.2% (95% CI: 90.1–98.4%) sensitivity, 93.7% (91.5–95.9%) specificity, 79.2% (72.5–85.8%) positive predictive value (PPV), and 98.5% (97.3–99.6%) negative predictive value (NPV). The high PPV algorithm had 75.2% (67.5–82.9%) sensitivity, 98.3% (97.2–99.5%) specificity, 91.9% (86.6–97.3%) PPV, and 94% (91.9–96.1%) NPV. Combining high PPV and high sensitivity algorithms with additional (7.5%) chart review to resolve discordant cases resulted in 94.2% (90.1–98.4%) sensitivity, 98.3% (97.2–99.5%) specificity, 93.4% (89.1–97.8%) PPV, and 98.5% (97.4–99.6%) NPV. Conclusion The proposed algorithms based on routinely collected administrative data achieved favorably high validity for identifying breast cancer recurrences in a universal healthcare system in Canada.
dc.identifier.citationBMC Cancer. 2019 Mar 08;19(1):210
dc.identifier.doihttps://doi.org/10.1186/s12885-019-5432-8
dc.identifier.urihttp://hdl.handle.net/1880/110051
dc.language.rfc3066en
dc.rights.holderThe Author(s).
dc.titleDevelopment and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12885_2019_Article_5432.pdf
Size:
1020.83 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: